SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-269957
Filing Date
2024-12-03
Accepted
2024-12-03 16:34:49
Documents
2
Group Members
CHEN YUTCG CROSSOVER FUND II, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G d837379dsc13g.htm SC 13G 71840
2 EX-99.1 d837379dex991.htm EX-99.1 4930
  Complete submission text file 0001193125-24-269957.txt   78509
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Subject) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88806 | Film No.: 241523281
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 705 HIGH STREET PALO ALTO CA 94301
Business Address 705 HIGH STREET PALO ALTO CA 94301 650-924-9424
TCG Crossover GP II, LLC (Filed by) CIK: 0001969280 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G